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Abstract
Background: Many mechanistic steps underlying nutrient-stimulated insulin secretion (NSIS) are
poorly understood. The influence of intracellular pH (pHi) on insulin secretion is widely
documented, and can be used as an investigative tool. This study demonstrates previously unknown
effects of pHi-alteration on insulin secretion in mouse islets, which may be utilized to correct
defects in insulin secretion.
Methods: Different components of insulin secretion in mouse islets were monitored in the
presence and absence of forced changes in pHi. The parameters measured included time-
dependent potentiation of insulin secretion by glucose, and direct insulin secretion by different
mitochondrial and non-mitochondrial secretagogues. Islet pHi was altered using amiloride, removal
of medium Cl-, and changing medium pH. Resulting changes in islet pHi were monitored by confocal
microscopy using a pH-sensitive fluorescent indicator. To investigate the underlying mechanisms of
the effects of pHi-alteration, cellular NAD(P)H levels were measured using two-photon excitation
microscopy (TPEM). Data were analyzed using Student's t test.
Results:  Time-dependent potentiation, a function normally absent in mouse islets, can be
unmasked by a forced decrease in pHi. The optimal range of pHi for NSIS is 6.4–6.8. Bringing islet
pHi to this range enhances insulin secretion by all mitochondrial fuels tested, reverses the inhibition
of glucose-stimulated insulin secretion (GSIS) by mitochondrial inhibitors, and is associated with
increased levels of cellular NAD(P)H.
Conclusions: Pharmacological alteration of pHi is a potential means to correct the secretory
defect in non-insulin dependent diabetes mellitus (NIDDM), since forcing islet pHi to the optimal
range enhances NSIS and induces secretory functions that are normally absent.
Background
Nutrient-stimulated insulin secretion (NSIS) in the pan-
creatic β cell consists of three distinct components with
different underlying mechanisms. These components
include a) an initial peak (first phase) triggered by Ca2+, b)
augmentation of the Ca2+-triggered response (second
phase), and c) a memory that persists after removal of the
nutrient, causing enhancement of subsequent secretory
responses (time-dependent potentiation) [1-4]. The first
phase of the insulin response is initiated by ATP derived
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from glucose metabolism, which leads to membrane
depolarization through closure of ATP-dependent K+
channels (KATP channels) and consequent entry of extra-
cellular Ca2+ through voltage-gated Ca2+ channels. This
influx of Ca2+ triggers the release of a small pool of secre-
tory granules, thus producing the initial peak of the insu-
lin response [1]. This peak is followed by a sustained
second phase of insulin release that lasts through the
duration of exposure to the nutrient, believed to be medi-
ated through augmentation of the Ca2+-triggered first-
phase response [1]. Time-dependent potentiation (TDP),
a positive memory induced during this acute response,
magnifies subsequent secretory responses to all secretago-
gues [2,4-6].
While any secretagogue that causes an adequate increase
in Ca2+ will stimulate the first phase insulin release, the
complete range of secretory functions (initiation, aug-
mentation and TDP) can only be produced by com-
pounds that enhance cellular metabolism. The
mechanisms underlying the augmentation and memory
pathways are poorly understood. Both augmentation and
TDP are independent of KATP channels [7-9]. The glucose-
induced augmentation pathway has both Ca2+-dependent
and Ca2+-independent components [10,11], while TDP is
largely independent of Ca2+  [12-14]. These functions
show considerable species variation. TDP is present only
in certain species such as humans and rats, while the
nature of the augmentation response differs between spe-
cies [1-3,15-17]. Elucidating the mechanisms of these dif-
ferent secretory pathways is important in designing new
therapeutic measures for diabetes, since NIDDM affects
each pathway differently [2,5,18]. TDP is of particular
physiological importance. While the direct insulin
response to glucose is usually impaired in NIDDM, the
potentiating function of glucose can remain intact. In
some diabetic subjects, the defective insulin response to
glucose can be restored to normal by inducing TDP
[18,19]. A potential therapeutic approach for such cases is
to stimulate TDP by means other than glucose, thus
enhancing the secretory ability of the β cell and enabling
the body to better handle the hyperglycemia. In other
forms of NIDDM, both the acute insulin release and TDP
are impaired [20-22] and the correction of the defect in
the TDP pathway may automatically correct the defect in
direct insulin release.
There is strong evidence that NSIS is influenced by pHi.
Most reports on this subject show that a decrease of pHi is
favorable for GSIS and related functions such as Ca2+
influx and K+ retention, while intracellular alkalinization
is inhibitory to all these functions [23-31]. The optimal
pHi for insulin secretion by both glucose and alpha-ketoi-
socaproate (αKIC) in rat islets is reported to be 0.09 units
below basal [32]. Glucose-stimulated TDP in rat islets is
critically dependent on an appropriate pHi [12], and TDP
produced by other mitochondrial fuels also show similar
pHi-dependence [Unpublished observations: SC Guna-
wardana, YJ Liu, SG Straub and GWG Sharp].
While these studies clearly demonstrate that pHi affects
insulin secretion, further work is necessary to determine
a) the specific components of each secretory pathway
affected by pHi, b) the underlying mechanisms of such
effects, and c) the possible therapeutic value of the influ-
ence of pHi on insulin release. Furthermore, information
on the effects of pHi in mouse islets is somewhat limited,
and, although the majority of the literature indicates that
below-basal pHi is favorable for insulin secretion, there
are some reports to the contrary [32-34]. Such discrepan-
cies may be due to the differences in media and pHi-meas-
urement techniques used. In this study, using a more
accurate modern technique of pHi-measurement [35], we
have investigated the effects of pHi on different compo-
nents of NSIS in mouse islets, and explored the possible
mechanisms of such effects. Specific aims were to deter-
mine whether pHi-manipulation would a) enable glucose
to induce TDP in mouse islets, where it is normally
absent; b) influence direct insulin secretion via both mito-
chondrial and non-mitochondrial signals; and c) produce
changes in cellular metabolism, as indicated by NAD(P)H
levels.
Our results demonstrate a strong dependence of NSIS on
pHi, and the ability of the appropriate pHi to allow secre-
tory functions that are otherwise absent. They also suggest
that enhanced nutrient metabolism plays a role in the
favorable effects of below-basal pHi on NSIS.
Methods
Animals
Male C57BL6 mice aged 4–8 weeks obtained from Harlan
Laboratories (Indianapolis, IN) were used for all experi-
ments. The animals were cared for according to the guide-
lines of the Vanderbilt Institutional Animal Care and Use
Committee.
Media
Islets were isolated in Hanks Balanced Salt solution, and
HEPES-buffered Krebs Ringer Bicarbonate solution
(KRBH) was used for the major part of the static incuba-
tions in secretion experiments. The components of KRBH
are as follows: 128.8 mM NaCl; 4.8 mM KCl; 1.2 mM
KH2PO4; 1.2 mM MgSO4; 2.5 mM CaCl2; 5 mM NaHCO3
-
and 10 mM HEPES. In the Cl--free KRBH medium used for
intracellular alkalinization, gluconate salts were used in
place of Cl- salts. The medium pH was maintained at 7.4,
except in the media used for intracellular alkalinization
where the pH was raised above 8.3 by addition of NaOH.
Basal KRBH used for pre-incubation and non-stimulatedBMC Endocrine Disorders 2004, 4 http://www.biomedcentral.com/1472-6823/4/1
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controls contained 2.8 mM glucose, while the stimulating
media contained either 16.7 mM glucose, or other secret-
agogues as indicated in the presence of 2.8 mM glucose. In
pHi-alteration experiments, 40 µM di-methyl amiloride
(DMA) was added to the medium to produce intracellular
acidification, and a Cl--free medium, a high pH (>8.3)
medium, or a combination of both, were used for intrac-
ellular alkalinization. In preparation for imaging experi-
ments, islets were cultured in RPMI 1640 culture medium
supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, 0.1 g/L streptomycin and 11 mM glucose.
Secretagogues
In addition to 16.7 mM glucose, the following mitochon-
drial secretagogues were used to stimulate direct insulin
secretion. a) methyl pyruvate (MP), the methylated form
of the glycolytic end product of glucose, b) leucine, an
amino acid metabolized solely in the mitochondria, c)
αKIC, a metabolic product of leucine, and d) 2-amino-
bicyclo[2,2,1]heptane-2-carboxylic acid (BCH), a non-
metabolizable analog of leucine which enhances TCA
cycle activity only through allosteric activation of gluta-
mate dehydrogenase (GDH) [36-38]. None of these com-
pounds are metabolized in the cytosol, and their
metabolic effects are exerted solely in the mitochondria.
The non-mitochondrial secretagogues used were a) high
K+, which directly stimulates insulin secretion through
depolarization-induced Ca2+-influx, activating the first
phase of insulin release, and b) glucose combined with
inhibitors that prohibit the entry of glycolytically-derived
pyruvate and NAD(P)H into mitochondria, thus eliminat-
ing the mitochondrial component of glucose metabolism
while leaving the glycolytic component intact [39]. The
inhibitors included α-hydroxycyanocinnamic acid
(CHC), an inhibitor of mitochondrial pyruvate transport,
and amino-oxy acetic acid (AOA), an inhibitor of the
malate aspartate shuttle that transports glycolytic
NAD(P)H into mitochondria [39].
Isolation of islets
A modified version of the collagenase digestion method
described by Lacy and Kostianovsky [40] was used. Mice
were anesthetized with intra-peritoneal injection of Keta-
mine/Xylazine (80/20 mg/Kg). Pancreas was removed,
placed in ice-cold Hanks solution and minced with scis-
sors. Collagenase (3 mg/ml) was added and the mixture
shaken in a 37°C water bath until the tissue was ade-
quately digested. The mixture was then centrifuged, super-
natant removed and the pellet re-suspended in Hanks
solution. Centrifugation and re-suspension were repeated
several times to remove exocrine tissue. The final pellet
was re-suspended either in basal KRBH medium for secre-
tion experiments or RPMI medium for islet culture. Islets
were hand picked under a stereomicroscope.
Culture of islets
The method described by Arkhammar et al. 1998 [41] was
used with minor modifications [39,42]. 35 mm culture
dishes with glass-bottomed wells (Mat-Tek corporation)
were used. The dishes were pre-prepared by coating the
wells with human extracellular matrix (BD Biosciences).
Freshly isolated islets were placed carefully in each well,
covered with RPMI medium containing 11 mM glucose,
and cultured at 37°C in 95% O2 and 5% CO2. Under these
conditions, the cells in the islet spread out within 14 days,
greatly reducing the islet thickness and making it particu-
larly suitable for imaging with confocal microscopy. An
advantage of this culture technique is that it does not sig-
nificantly disrupt islet architecture, thus allowing islet
cells to maintain normal functions. Although the islet
spreads out over the matrix, islet cells do not separate
from each other, and the gap junctions between cells con-
tinue to function. Islets cultured for two weeks under
these conditions exhibit normal responses of Ca2+,
NAD(P)H and insulin release to glucose stimulation
[39,41,42], providing an excellent model for imaging
studies whose results can be safely extrapolated to fresh
islets.
Intracellular pH measurements
The changes in islet pHi produced by each secretagogue
and by different pHi-alteration techniques were moni-
tored by confocal microscopy, using carboxy-seminaph-
thorhodofluor-5 (SNARF5) [35], a pH-sensitive
fluorescent indicator. Prior to imaging, cultured islets
were maintained in RPMI medium containing 5 mM glu-
cose for 48 hours. On the day of the experiment, RPMI
medium was removed, and islets were washed and placed
in basal KRBH medium. SNARF5-AM (5 µM final concen-
tration) was added and incubated for one hour at 37°C.
Loaded islets were placed on a warmed stage in a humid-
ified and temperature-controlled chamber at 37°C, and
monitored with a F-Fluar 40 × 1.3 NA oil immersion lens
of a LSM510 confocal laser-scanning microscope (Zeiss).
Islets were excited at 514 nm with an argon laser, and the
emission fluorescence was collected in the band-widths
568–589 nm and 621–643 nm (peak emission at 580 and
630 nm) using the Meta detector (Zeiss). Time-series
images (2.56 µs/pixel) were collected for 5–20 minutes as
was suitable for each experiment. A stable baseline was
obtained before the actual recording for each experimen-
tal condition started. LSM software was used to calculate
the ratio between the two emission fluorescence values
from selected well-loaded regions in each islet. This ratio
was proportional to the islet pHi. The results were ana-
lyzed using LSM software, Graphpad Prism, and Microsoft
Excel. One representative recording for each experimental
condition is shown in the results section, and the value n
denotes the number of recordings done with different
islets for each condition. The pHi  change for eachBMC Endocrine Disorders 2004, 4 http://www.biomedcentral.com/1472-6823/4/1
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condition is the difference between the average pHi of the
baseline and the average pHi over a stable region of the
recording after treatment. The pHi changes from n record-
ings were averaged to obtain the "average pHi change"
shown in the results section and in the legend for each fig-
ure. A standard curve was prepared by fixing the islet pHi
at known values (ranging from 5.5 to 9, with 5–10 islets
for each pH), using a KRBH medium containing 100 mM
K+ and 20 mM nigericin to equilibrate the pH inside and
outside cells.
Secretion measurements
All incubations were done in a 37°C water bath. Freshly
isolated islets were pre-incubated for one hour in basal
KRBH containing 2.8 mM glucose. Islets were then
divided into groups and stimulated with different com-
pounds as indicated in the results section, for one hour.
Control group was maintained in basal glucose. At the
end of the stimulation period, samples were collected for
insulin measurement by radio-immuno-assay (performed
by the DRTC Core facility at Vanderbilt University). Islet
insulin content was measured after freezing islets over-
night in 2% Triton-X. Insulin secretion was expressed as
fractional release, i.e. the percentage of total insulin con-
tent released over the period of stimulation. In the exper-
iments monitoring TDP, after pre-incubation islets were
exposed to high (16.7 mM) glucose with or without intra-
cellular acidification for 40 minutes, while the control
group was exposed to basal glucose. Subsequently all
groups were rested in basal glucose for 30 minutes, and
stimulated with high glucose for one hour prior to collec-
tion of samples for insulin assay. The value n denotes the
number of times each experiment was repeated using
islets from different mice.
Imaging of NAD(P)H
Experiments were performed using TPEM combined with
techniques developed in our lab. a) Two-photon fluores-
cence imaging: Prior to imaging, cultured islets were main-
tained in RPMI medium containing 5 mM glucose for 24–
48 hours. On the day of the experiment, RPMI medium
was removed, and islets were washed and placed in basal
KRBH medium. Two-photon imaging was done using a
Plan-Apochromat 60 × 1.4 NA oil immersion lens of a
LSM510 confocal laser-scanning microscope (Zeiss). Islets
were kept at 37°C and high humidity using a temperature
controlled stage and objective warmer (Zeiss). Sequential
images of autofluorescence were collected using 710 nm
excitation with a Coherent Mira laser tuned to 710 nm.
Each image was collected with a single scan using slow
speed (6.4 µs/pixel) and 0.1 µm/pixel. The laser power
used provides ~3.5 mW to the surface, at which power no
observable damage is caused to the islet [43] even after 60
minutes of continuous imaging [44]. Non-descanned
NAD(P)H fluorescence was collected through a custom
380- to 550-nm filter (Chroma). b) Standard Curve: Stand-
ard solutions of NADH bound to yeast alcohol dehydro-
genase were imaged in deep well slides using live cell data
collection settings. This solution closely resembles cellular
NAD(P)H since a majority of NAD(P)H is enzyme bound
in the cellular environment [45]. NADH was titrated into
a solution of ~100 mg/ml alcohol dehydrogenase, 10 mM
ethanol, 100 mM isobutyramide, 6 mM semicarbazide,
and 10 mM HEPES (pH 9.0). c) Image Analysis: Images
were exported in tagged image file format (tiff) for analy-
sis using MetaMorph software (version 5.0). Images were
filtered using a 5 × 5 median filter. An intensity threshold
was first set in the NAD(P)H image to isolate the bright
mitochondria. In each image the maximum intensity
from the mitochondrial regions was averaged. This aver-
age represents the best average intensity of the in focus
mitochondria for the image. A threshold was set on the
median filtered image to isolate cytoplasmic NAD(P)H
intensity. The low end of this threshold excluded nuclear
regions and the high end partially excluded brighter mito-
chondrial regions. A binary mask was made from the
threshold. This mask was then eroded, dilated, and seg-
mented to remove noise pixels in the background regions
and generate a number of cytoplasmic regions. These
regions were transferred to the median filtered image and
the mean intensity of these regions was calculated as the
average cytoplasmic NAD(P)H intensity.
Statistical analysis
Values are expressed as mean ± SEM. Groups were com-
pared using paired Student's t test. In secretion studies, n
denotes the number of times each experiment was
repeated with islets from different mice. In imaging exper-
iments for pHi and NAD(P)H, n denotes the number of
islets imaged for each condition.
Results
SNARF5-AM as a pHi-indicator for islets
SNARF5-AM loaded efficiently into a significant portion
of the β cell-rich region of each islet, and emitted bright
fluorescence when excited at 514 nm. Changes in the
emission ratio 630/580 were directly proportional to
changes in islet pHi, indicating SNARF5-AM to be a suita-
ble dye to monitor pHi in mouse islets. (Fig. 1). The basal
pHi in islets (in KRBH with basal glucose) fell within the
range of 6.9–7.2 with an average of 7.09 ± 0.01 (n = 72),
and remained stable until additions/changes were made.
Selecting methods for pHi-alteration
We tested several traditional methods of pHi-alteration,
including the addition of weak acids or amiloride deriva-
tives (inhibitors of the Na+/H+ exchanger) for acidifica-
tion, and addition of weak bases, removal of medium Cl-
, or raising the medium pH for intracellular alkaliniza-
tion. The pHi changes produced by weak acids or basesBMC Endocrine Disorders 2004, 4 http://www.biomedcentral.com/1472-6823/4/1
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were sharp but very transient (data not shown), making
these methods unsuitable for altering pHi over a long
period. In contrast, DMA produced a slow, steady and sus-
tained decrease of pHi, bringing it down by 0.2–1.0 pH
units from baseline, with an average decrease of 0.5 ± 0.07
pH units (Fig. 2A). Removal of medium Cl-, or raising the
medium pH above 8.3, both produced sustained increases
in pHi, but the magnitude of the change was small, rang-
ing from 0.1–0.4 units, with an average increase of 0.3 ±
0.05 and 0.24 ± 0.03, respectively (Fig. 2B &2C). There-
fore, none of the traditional pHi-increasing methods
Changes in emission fluorescence of SNARF5, in response to  changes in intracellular pH Figure 1
Changes in emission fluorescence of SNARF5, in 
response to changes in intracellular pH: Islets loaded 
with SNARF5-AM (5 µM) were fixed at known intracellular 
pH values by placing them in KRBH solutions containing 100 
mM K+ and 20 µM nigericin, adjusted to different pH values. 
Islets were excited at 514 nm, and emission fluorescence 
recorded at 580 and 630 nm. Emission fluorescence at 580 
and 630 nm are denoted by red and green respectively. Top: 
Islets at intracellular pH 6, 7, and 8. As pH increases, red flu-
orescence decreases and green fluorescence increases. Bot-
tom: Standard curve prepared using islets fixed at pHi values 
ranging from 5.5–9.0. n = 5–10 islets for each pH.
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Effect on islet pHi by different pH-altering methods Figure 2
Effect on islet pHi by different pH-altering methods: 
Islets loaded with SNARF5-AM were placed in basal KRBH, 
excited at 514 nm and emission fluorescence recorded at 
580 and 630 nm. After a steady baseline was established, 
additions/substitutions were made as denoted in each figure. 
One representative recording for each condition is shown. 
A. 40 µM DMA: n = 16, average pH change = 0.5 ± 0.07; B. 
Removal of medium Cl-: n = 5, average pH change = 0.3 ± 
0.06; C. Switching to a high pH (>8.3) medium: n= 6, average 
pH change = 0.24 ± 0.03; D. Switching to a Cl--free and high 
pH (>8.3) medium: n = 8, average pH change = 0.5 ± 0.06
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appeared suitable for producing a sufficient increase in
pHi for one hour. However, combination of the latter two
methods, i.e. using a Cl--free high pH medium, proved to
be an effective technique for prolonged increase of pHi by
0.3–0.7 units, with an average change of 0.5 ± 0.06. (Fig.
2D)
Effect of pHi on glucose-induced TDP
As has been shown before, TDP does not occur in mouse
islets [15-17]. Remarkably, glucose induced a strong TDP
response in mouse islets in the presence of intracellular
acidification by DMA (Fig. 3). In other words, while the
secretory response in mouse islets is not normally affected
by a previous exposure to glucose, it was greatly magnified
when the previous exposure to glucose was combined
with lowered pHi. It is noteworthy that the pHi change
caused by DMA does not persist once DMA is removed
from the medium (data not shown), so that the enhance-
ment of the subsequent secretory response to glucose is
caused purely by a memory effect. Since lowering pHi can
induce/unmask a secretory function which is normally
absent, it is very likely that pHi has a strong influence on
direct insulin secretion as well.
Effect of pHi-alteration on direct insulin secretion by 
mitochondrial secretagogues, and effect of different 
mitochondrial fuels on pHi
Previous studies have shown that GSIS is enhanced by
intracellular acidification and inhibited by intracellular
alkalinization [23-32]. Our preliminary studies confirmed
this, and showed that even weak methods of alkaliniza-
tion (such as removal of medium Cl-  or raising the
medium pH above 8.3) significantly inhibit GSIS (Fig.
4A).
Among the mitochondrial secretagogues tested, leucine,
αKIC (metabolic product of leucine) and BCH (non-
metabolizable analog of leucine) all produced significant
insulin secretion, to a lesser degree than glucose. As
expected, insulin secretion by all these agents showed a
strong correlation with pHi. Decrease of pHi by DMA
caused a marked increase in the insulin secretion, making
the magnitude of the secretory response close to that of
glucose. Insulin release by all three agents was signifi-
cantly inhibited by a strong increase in pHi, as produced
by a Cl--free high pH medium (Fig. 4B,4C &4D).
Interestingly, weaker methods of alkalinization were not
sufficient to inhibit the insulin release by leucine, KIC and
BCH, unlike with glucose (data not shown). This differ-
ence can be explained by the direct effect of each nutrient
on intracellular pH. As shown in Table 1, glucose pro-
duced a significant increase in pHi. This was further
increased even by weaker methods of alkalinization, so
that high glucose in a high pH medium (Table 1) or Cl--
free medium (data not shown) resulted in a prolonged
increase of pHi to 7.5 or higher. A high pH medium (Table
1) or Cl--free medium (data not shown) alone was not
adequate to produce such a rise in pHi, with or without
the presence of other fuels such as leucine, BCH or αKIC.
Therefore, while any method of alkalinization combined
with glucose can drive the pHi above the range favorable
for secretion, weaker methods of alkalinization still main-
tain the pHi within this favorable range in the presence of
other mitochondrial fuels (Table 1). Insulin release by
these compounds could be inhibited only when pHi was
driven above 7.5 by a Cl--free high pH medium (Fig.
4B,4C &4D).
Glucose induces TDP in mouse islets in the presence of  DMA Figure 3
Glucose induces TDP in mouse islets in the presence 
of DMA: Insulin secretion in response to 16.7 mM glucose, 
from freshly isolated islets that were previously exposed to 
different conditions as denoted in the X axis. All groups were 
first pre-incubated in basal glucose for one hour. During the 
next 40 minutes, islets were exposed to 2.8 or 16.7 mM glu-
cose with and without 40 µM DMA. Following a subsequent 
rest period of 30 minutes in basal glucose, all groups were 
exposed to 16.7 mM glucose for one hour and samples col-
lected for insulin assay. Insulin secretion is expressed as frac-
tional release %, i.e. the percentage of the total insulin 
content released over the one-hour period of stimulation 
with 16.7 mM glucose. n = 8; G = mM glucose; * = p < 
0.0001, compared with all other groups.
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Effect of experimental alteration of pHi on direct insulin secretion by mitochondrial secretagogues Figure 4
Effect of experimental alteration of pHi on direct insulin secretion by mitochondrial secretagogues: Insulin 
secretion from freshly isolated islets, in response to different secretagogues as indicated, with and without intracellular pH 
altered. Controls are in 2.8 mM and 16.7 mM glucose, and test groups are in leucine, αKIC or BCH, 20 mM each. Intracellular 
acidification was produced by 40 µM DMA. Intracellular alkalinization was produced by either a Cl--free medium (A), a high pH 
(>8.3) medium (A), or a combination of both (B-D). All groups were first pre-incubated in basal glucose for one hour, and sub-
sequently exposed to each condition denoted in the X axes for one hour, followed by sample collection for insulin assay. Insu-
lin secretion is expressed as fractional release %, i.e. the percentage of the total insulin content released over the one-hour 
period of stimulation with different agents. G = mM glucose; Leu = leucine. A) Glucose: n = 6; * = p < 0.001; and † = p < 0.05, 
compared to stimulated control in high glucose without pHi-alteration. B) Leucine: n = 5; * = p < 0.001, and † = p < 0.05, com-
pared to leucine without pHi-alteration. C) BCH: n = 5; * = p < 0.001, compared to BCH without pHi-alteration. D) αKIC: n = 
8; * = p < 0.001, and † = p < 0.05, compared to αKIC without pHi-alteration.
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The inability of pyruvate to stimulate insulin release is
puzzling, and has been widely studied [39,46,47]. We
used the methylated form of pyruvate (MP), which is
known to penetrate cellular membranes better than pyru-
vate [48-51], as one of the mitochondrial stimulants. In
our hands, MP did not stimulate insulin secretion, with or
without acidification by DMA (Fig. 5A). Interestingly, MP
caused a dramatic and prolonged decrease in pHi (ranging
from 0.7–1.7 units from baseline, with an average
decrease of 1.0 ± 0.08 pH units), providing a possible
explanation for its lack of secretion (Fig. 5B). If the lack of
secretion by MP is due to inappropriately low pHi, then a
forced increase of pHi should allow it to stimulate insulin
release. While the weaker methods of alkalinization were
not adequate to reverse the acidifying effect of MP, a Cl--
free high pH medium did reverse it, bringing the pH back
to the range of 6.4–7.0 (Fig. 5C,5D &5E). As expected,
reversing the acidifying effect of MP by a Cl--free high pH
medium did allow MP to stimulate significant insulin
secretion. (Fig. 5F).
Effect of pHi-alteration on direct insulin secretion by non-
mitochondrial secretagogues
High K+  causes insulin exocytosis via depolarization-
induced Ca2+-influx, and does not involve nutrient
metabolism or ATP production. K+-induced insulin secre-
tion was slightly but not significantly enhanced by intrac-
ellular acidification, and was not affected by
alkalinization (Fig. 6A).
Glucose is converted to a non-miotchondrial secretagogue
by combining with the mitochondrial inhibitors AOA and
CHC [39]. As expected, the presence of these inhibitors
caused a significant reduction in the insulin response by
glucose. Remarkably, intracellular acidification by DMA
not only reversed this inhibition, but enhanced the insu-
lin secretion further than that produced by glucose alone
(Fig. 6B). This suggests that the effect of pHi is not limited
to mitochondrially-derived signals, and that extra-mito-
chondrial signals alone can induce significant insulin
secretion when pHi is within the favorable range.
Effect of intracellular acidification on cellular NAD(P)H 
levels
To explore the mechanisms whereby DMA reversed the
inhibition of GSIS by AOA and CHC, we monitored insu-
lin secretion and cellular NAD(P)H response in the pres-
ence/absence of DMA and the inhibitors. While DMA
enables glucose to stimulate insulin release in the pres-
ence of inhibitors (Fig. 6B), DMA alone does not stimu-
late insulin secretion (Fig. 4A). As shown in fig. 7,
however, DMA did increase whole cell NAD(P)H levels in
all situations tested, including basal or high glucose with
and without inhibitors. It is interesting that DMA
increased NAD(P)H at basal glucose levels (Open bars: no
additions vs. DMA, and AOA/CHC vs. AOA/CHC/DMA).
This is likely due to an increase in NADPH rather than
NADH, based on the fact that DMA alone does not cause
insulin secretion. High glucose induced similar increases
in NAD(P)H in the absence or presence of DMA, suggest-
ing that DMA does not stimulate glucose utilization
beyond normal. However, when glucose metabolism is
inhibited with AOA and CHC, DMA treatment allowed
glucose to induce similar changes as those observed in the
absence of the inhibitors. This suggests that DMA
treatment somehow enables the full utilization of glucose.
To further investigate the metabolic effect of low pHi, we
looked at the effect of DMA on cytosolic and mitochon-
drial NAD(P)H levels in the presence and absence of
nutrients whose secretory ability is enhanced at low pHi.
Both in the presence and absence of nutrients (16.7 mM
glucose or 20 mM αKIC), DMA produced a dramatic
increase in cytoplasmic NAD(P)H levels (Fig. 8A), and a
smaller but significant increase in the mitochondrial
NAD(P)H levels (Fig. 8B). Again, glucose-induced
increases in the NAD(P)H response (both cytoplasmic
and mitochondrial) were of similar magnitude in the
absence or presence of DMA.
Discussion
Even though the influence of pHi  on GSIS has been
known for many years, there is some controversy on the
nature of these effects, and little attention has been paid
Table 1: Islet pHi (mean ± SEM) in the presence of each secretagogue
Nutrient In Basal pH medium In High pH medium
Glucose 16.7 mM 7.32 ± 0.04 7.55 ± 0.03
Leucine 20 mM 7.09 ± 0.03 7.23 ± 0.04
BCH 20 mM 7.06 ± 0.03 7.24 ± 0.03
αKIC 20 mM 6.99 ± 0.02 7.18 ± 0.03
Islets loaded with SNARF5-AM were placed in KRBH medium of either basal pH (7.4) or high pH (8.3), containing each secretagogue. Islets were 
excited at 514 nm and emission fluorescence recorded at 580 and 630 nm. Average intracellular pH was calculated over a stable region of each 
recording, and these values from n recordings were averaged to obtain the pH values shown in the table. n = 10 for glucose; 6 for leucine and BCH; 
5 for αKIC.BMC Endocrine Disorders 2004, 4 http://www.biomedcentral.com/1472-6823/4/1
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Insulin secretion and pHi-changes produced by MP Figure 5
Insulin secretion and pHi-changes produced by MP: A. MP does not stimulate insulin release, even with intracellular 
acidification: Insulin secretion in response to 20 mM MP with and without intracellular acidification, from freshly isolated islets. 
Controls were exposed to 2.8 mM and 16.7 mM glucose. All groups were first pre-incubated in basal glucose for one hour, and 
subsequently exposed to each condition denoted in the X axis for one hour, followed by sample collection for insulin assay. 
Insulin secretion is expressed as fractional release %, i.e. the percentage of the total insulin content released over the one-hour 
period of stimulation with different agents. Intracellular acidification was produced by addition of 40 µM DMA. G = mM glu-
cose. n = 6. B. MP produces a drastic decrease in intracellular pH: Islets loaded with SNARF5-AM were placed in basal KRBH, 
excited at 514 nm and emission fluorescence recorded at 580 and 630 nm. After a steady baseline was established, 20 mM MP 
was added where indicated. One representative recording is shown. n = 16; average decrease in pHi = 1.0 ± 0.08. C and D. MP-
induced acidification is not affected by traditional methods of alkalinization: Same procedure as in B. Islets were switched to Cl-
-free medium (C) or high pH (>8.3) medium (D), as indicated, before addition of MP. One representative recording for each 
condition is shown. C: n = 3; D: n = 4. E. MP-induced acidification is reversed by a Cl--free high pH medium: Islets loaded with 
SNARF5-AM were placed in Cl--free KRBH of pH above 8.3, excited at 514 nm and emission fluorescence recorded at 580 and 
630 nm. 20 mM MP was added where indicated. One representative recording is shown. n = 8. Average pHi in Cl--free high pH 
medium = 7.5 ± 0.04; Average lowest pHi after addition of MP = 6.1 ± 0.12; Average pHi after recovery = 6.9 ± 0.1; pHi range 
after recovery = 6.4–7.0 F. MP stimulates insulin secretion when pHi is brought back to 6.4–7.0 by strong alkalinization: Same 
procedure as in A. Intracellular alkalinization was produced by exposure to a Cl--free high pH (>8.3) medium. G = mM glucose; 
n = 8; * = p < 0.001, compared to MP without alkalinization or basal glucose control.
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Effect of experimental alteration of pHi on insulin secretion by non-mitochondrial secretagogues Figure 6
Effect of experimental alteration of pHi on insulin secretion by non-mitochondrial secretagogues: A. Insulin 
secretion by high K+ is not significantly influenced by pHi-alteration: Insulin secretion in response 50 mM K+ with and without 
pHi-alteration techniques (40 µM DMA for acidification and a Cl--free high pH medium for alkalinization) from freshly isolated 
islets. Control groups were exposed to 2.8 mM and 16.7 mM glucose. All groups were first pre-incubated in basal glucose for 
one hour, and subsequently exposed to each condition denoted in the X axis for one hour, followed by sample collection for 
insulin assay. Insulin secretion is expressed as fractional release %, i.e. the percentage of the total insulin content released over 
the one-hour period of stimulation with different agents. n = 7; G = mM glucose. B. GSIS is inhibited by AOA and CHC. This 
inhibition is reversed by DMA: Insulin secretion in response to glucose combined with AOA and CHC (5 mM each) in the 
presence or absence of 40 µM DMA, from freshly isolated islets. All groups were first pre-incubated in basal glucose for one 
hour, and subsequently exposed to each condition denoted in the X axis for one hour, followed by sample collection for insulin 
assay. Insulin secretion is expressed as fractional release %, i.e. the percentage of the total insulin content released over the 
one-hour period of stimulation with different agents. G = mM glucose. n = 5; * = p < 0.001, compared with high glucose alone, 
or with high glucose with inhibitors and DMA added.
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to the mechanisms and physiological implications of such
effects. This could be due in part to the lack of accurate
methods for monitoring pHi. Previous methods used for
measuring pHi include carboxyfluorescein, BCECF, and
intracellular microelectrodes. SNARF, a relatively new
class of pH indicators, is more suitable due to efficient
loading and retention in the cells, as well as being a ratio-
metric dye which minimizes variation due to differences
in loading or fluctuations of laser intensity. Simple car-
boxy SNARF-AM esters are particularly suitable for meas-
uring cytosolic pH exclusively, as these compounds,
loaded under the current conditions, remain localized in
the cytosol. (The more complex carboxy SNARF-calcein-
AM form, which accumulates in cellular organelles, is bet-
ter suited for measuring pH in selected organelles). Car-
boxy SNARF-AM esters diffuse through the cell membrane
and are hydrolyzed by cytosolic esterases, consequently
getting trapped in the cytosol with minimal leakage or
compartmentalization [52-56]. Recently developed
SNARF5 [35], with a pKa of 7.2, is most suitable for mon-
itoring the physiological pHi range (compared to SNARF1
(pKa 7.5), SNARF4 (pKa 6.4) or carboxyfluorescein (pKa
6.5)). In our experiments, SNARF5-AM loaded efficiently
into the cultured islets, even though the center of most
islets remained largely unstained due to the short loading
time. The pHi-calculations were done using regions-of-
interest chosen from selected well-loaded areas closer to
the center of each islet. Since the interior of mouse islets
consists almost entirely of β cells (other cell types being
concentrated on the outside) this technique ensured the
pH measurements being performed in β cells. Islets
loaded with SNARF5 showed consistent visible changes in
emission fluorescence proportional to changes of pHi
(Fig. 1).
DMA increases whole cell NAD(P)H, both in the presence  and absence of inhibitors Figure 7
DMA increases whole cell NAD(P)H, both in the 
presence and absence of inhibitors: Islets were placed in 
basal KRBH with or without mitochondrial inhibitors (AOA 
and CHC, 5 mM each) and/or 40 µM DMA, and NAD(P)H 
auto-fluorescence was measured by TPEM before and after 
addition of 16.7 mM glucose. NAD(P)H auto-fluorescence 
for each condition is expressed as a percentage of the con-
trol (basal glucose with no additions). n = 6; † = p < 0.05 and 
* = p < 0.002, when compared to the same condition with-
out DMA.
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DMA increases cytoplasmic and mitochondrial NAD(P)H  production Figure 8
DMA increases cytoplasmic and mitochondrial 
NAD(P)H production: Islets were placed in basal KRBH 
with or without 40 µM DMA. NAD(P)H auto-fluorescence in 
cytoplasmic (A) and mitochondrial (B) regions was measured 
by TPEM before and after addition of 16.7 mM glucose or 20 
mM αKIC. A. n = 6; * = p < 0.001, compared to same condi-
tion without DMA. B. n = 6 ; * = p < 0.05, compared to same 
condition without DMA.
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A remarkable finding in this study was that TDP by glu-
cose, a function normally absent in mouse islets, could be
induced simply by lowering the pHi with DMA. This indi-
cates that the absence of TDP in mouse islets is not due to
lack of the necessary mechanisms, but that these mecha-
nisms are normally inactive, and require the proper pHi
range for activation. This finding complements the results
of previous studies where a TDP-like function was
unmasked in mouse islets by activation of PKC [15,57],
and where TDP normally present in rat islets was greatly
enhanced by lowering pHi [12]. Since the induction of
TDP has been known to correct the secretory defect in cer-
tain diabetic patients [2,18,19], it should be worthwhile
to explore the therapeutic value of inducing TDP using
pHi-lowering drugs combined with non-glucose
secretagogues.
In addition to unmasking TDP, decrease of pHi signifi-
cantly influenced direct insulin release by mitochondrial
fuels. DMA produced a fall of islet pHi by 0.2–1.0 pH
units, bringing it down from the basal range of 6.9–7.2 to
the lower range of 6.4–6.8. All the mitochondrial fuels
tested produced strong insulin secretion when the pHi was
in this lower range, indicating a below-basal pHi to be
optimal for insulin secretion. MP, which failed to produce
insulin secretion, presumably due to its strong acidifying
effect, could be made to stimulate insulin release by forc-
ing the pHi back to this favorable range (Fig. 5). The mag-
nitude of insulin secretion normally produced by leucine,
αKIC and BCH, compounds that produce no significant
change in islet pHi, was also greatly enhanced by bringing
the pHi  to the lower range with DMA (Fig. 4).
Furthermore, NSIS was consistently inhibited by raising
the pH above 7.5. These results demonstrate that nutrients
can produce insulin secretion only within a certain range
of islet pHi whose upper margin is 7.5. The lower margin
may possibly fall around 6.3, as indicated by the data with
MP. The most favorable pHi range for secretion (as well as
for unmasking TDP) is near the lower end of this range,
between 6.4–6.8, as is the case when MP is combined with
a Cl--free high pH medium or when other non-acidifying
nutrients are combined with DMA. These results are in
agreement with many previous studies that showed a
decrease of pHi being associated with enhanced insulin
secretion, Ca2+-influx and electrical activity [23-31]. One
early study of particular relevance [32] indicated that a
below basal pHi is optimal for insulin secretion in rat
islets by both glucose and αKIC, but also showed that an
increase of extracellular pH up-to 7.8 can enhance insulin
secretion. While the latter result appears to differ from our
findings, the previous work did not show simultaneous
pHi measurements. Since the strong buffering capacity of
β cells prevents any significant increase of pHi until the
extracellular pH is increased above 8, the reported
increase of insulin release likely occurred while the intra-
cellular pH was still within the normal range.
It is known from this and previous studies that mitochon-
drial fuels alone can stimulate considerable insulin secre-
tion. The magnitude of such insulin release is less than
that of glucose, suggesting that mitochondrial metabo-
lism does not produce the full range of secretory signals
generated by glucose. However, our secretion data from
compounds such as leucine, αKIC and BCH show that
mitochondrial activation alone is adequate to produce
strong insulin secretion, as long as the pHi is maintained
in the appropriate lower range. Similarly, when the mito-
chondrial component of glucose metabolism is
eliminated with AOA and CHC (a situation which nor-
mally inhibits GSIS), glucose can still produce the full
magnitude of insulin release once the pHi is decreased
with DMA. Hence, an appropriate pHi can compensate for
those secretory signals that are lacking in each situation,
regardless of whether these signals originate in the cytosol
or mitochondria. Since carboxy SNARF-AM esters localize
in the cytosol with minimal compartmentalization, we
expect the current pHi-measurements to principally reflect
the cytosolic pH and not that of granules or other
organelles. It would, however, be very interesting to see
how intragranular pH and intra-mitochondrial pH affects
different components of insulin secretion. Manipulating
the loading conditions or using different SNARF-AM
derivatives can promote compartmentalization of the dye
into organelles, but more sophisticated techniques are
necessary to distinguish different organelles from each
other.
The mechanisms whereby a low pHi enhances or unmasks
secretory signals are unclear. Since the depolarization-
mediated insulin secretion by high K+  was not
significantly affected by pHi-alteration, it is not likely that
the distal steps of the secretory pathway are involved. The
positive influence of acidification was prominent only on
nutrient-derived signals, suggesting enhancement of
nutrient metabolism by H+ ions, possibly by activating
key metabolic enzymes. Some of the Ca2+-activated mito-
chondrial dehydrogenases such as α-ketoglutarate dehy-
drogenase and isocitrate dehydrogenase are activated by
low pH [58-61]. Glutamate dehydrogenase, a key enzyme
in the insulin secretion produced by BCH and leucine, is
also reported to be pH-sensitive [62]. By activating these
enzymes, H+ ions may enhance TCA cycle metabolism
and increase the production of secretory messengers, thus
enhancing the secretory capacity of mitochondrial fuels.
An indirect but accurate indication as to whether low pHi
enhances cellular metabolism can be obtained by measur-
ing metabolic products such as NADH and NADPH in the
presence of nutrients and acidifying agents. As shown in
Fig. 8, DMA significantly increases NAD(P)H production,BMC Endocrine Disorders 2004, 4 http://www.biomedcentral.com/1472-6823/4/1
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which leads to increased cytoplasmic NAD(P)H even in
the absence of stimulatory nutrients. A role for NAD(P)H
is further evidenced by the fact that DMA reverses the
inhibition of GSIS by AOA and CHC (Fig. 6B), and simul-
taneously raises NAD(P)H (Fig. 7). However, in spite of
the rise in NAD(P)H, DMA does not produce insulin
secretion in the absence of a nutrient secretagogue (Fig.
4A). Hence, it is possible that this rise represents NADPH
alone, which is insufficient to stimulate secretion, but pre-
pares the cellular environment for better secretion by
NADH-producing nutrients [39]. DMA-induced low pHi
may either activate NADPH-producing enzymes with
acidic pH-optimum, such as GDH [62], or inhibit
NADPH-utilizing enzymes with alkaline pH-optimum,
such as nitric oxide synthase [63-66]. As shown in previ-
ous studies with pyruvate [39], a rise in NADPH alone is
not sufficient to stimulate insulin secretion, but can
enhance secretion by NADH-generating nutrients. Thus, a
decrease in islet pHi activates or "primes" metabolic path-
ways to generate extra secretory signals so that nutrients
can perform their secretory function more efficiently.
The current results show that intracellular pH determines
the ability of nutrients to stimulate insulin secretion. This
is not surprising, since most biological functions are sen-
sitive to pH and have an optimal range of pH. However, it
is remarkable that the optimal pH-range for insulin secre-
tion is on the acidic side, and that a relatively small
increase of pH above the physiological range is enough to
strongly inhibit NSIS. Therefore, it is possible that a small
defect in pHi regulation may cause a significant defect in
insulin secretion. This is particularly relevant in NIDDM
where islet pHi can decrease below the normal range due
to plasma acidosis, or increase above the normal range
either through overcompensation for acidosis or due to
hyperglycemia. Such a mis-regulation of pHi may well
contribute to the secretory defect in NIDDM. Whether or
not this is the case, an experimental alteration of pHi to
bring it to the optimal range should still improve insulin
secretion in defective islets, and merits attention as a
potential therapeutic approach.
Conclusions
This study shows that islet pHi is a critical factor that deter-
mines the presence and magnitude of different aspects of
NSIS in mouse islets. The most favorable pHi for NSIS is
below basal, falling between 6.4 and 6.8. Forcing islet pHi
to this range a) enables glucose to induce TDP, a function
normally absent in mouse islets; b) enhances direct
insulin secretion by all mitochondrial secretagogues
tested; and c) overcomes the inhibition of GSIS produced
by mitochondrial inhibitors. These actions may be medi-
ated through increased nutrient metabolism, as evidenced
by the increase of cellular NAD(P)H levels associated with
lowered pHi. The favorable effect of below-basal pHi on
NSIS, particularly its ability to induce TDP, is of potential
therapeutic value for correcting the secretory defect in cer-
tain cases of NIDDM.
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